This week's highlights
Equity markets ticked higher last week printing fresh highs in the US. The Aussie dollar strengthened after a lower week prior and oil continued to climb. The best performing ETF for the week was BetaShares Global Energy Companies ETF (Hedged) (FUEL), finishing up 4.6%. It was closely followed by BetaShares Crude Oil Index ETF - Ccy Hedged (OOO) up 3.8% and ETFS FANG+ ETF (FANG) up 3.2%.
The worst performing ETFs were sector-based Australian financials. BetaShares S&P/ASX 200 Financials Sector ETF (QFN) and SPDR S&P/ASX 200 Financials ex A-REITS Fund (OZF) were both down 2.7%.
Net flows for the week were A$140m which consisted of A$200m of inflows and A$60m of outflows. The biggest inflows were seen in ActiveX Ardea Real Outcome Bond Fund (Managed Fund) (XARO) which had A$16m of inflows, and ETFS Physical Gold (GOLD) which had A$15.4m of inflows as gold remains popular with investors. The largest outflow was in the BetaShares Australian Equities Strong Bear (BBOZ) which saw A$10.1m of outflow.
Major developments are increasing at a rapid pace in biotechnology especially in the field of genomics. ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to US healthcare biotechnology companies. These companies are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering. Examples include the development of immunotherapy treatments and vaccines to treat human diseases. CURE has a one year total return of 9% to 25 June 2021.